Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Mark Levin

Affiliations

  • Large Shareholder, Director at Fulcrum Therapeutics Inc. (FULC), 2019-07-22
  • Director at Voyager Therapeutics Inc. (VYGR), 2019-06-17
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2018-09-04
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-08-24
  • Large Shareholder at Neon Therapeutics Inc. (NTGN), 2018-07-03
  • Large Shareholder at Myokardia Inc (MYOK), 2018-03-07
  • Large Shareholder at Allena Pharmaceuticals Inc. (ALNA), 2017-11-06
  • Large Shareholder at Cytomx Therapeutics Inc. (CTMX), 2017-10-19
  • Large Shareholder at Global Blood Therapeutics Inc. (GBT), 2017-06-16
  • Large Shareholder at Blueprint Medicines Corp (BPMC), 2017-03-20
  • Large Shareholder at Jounce Therapeutics Inc. (JNCE), 2017-02-03
  • Large Shareholder at Sage Therapeutics Inc. (SAGE), 2016-08-19
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-16
  • Large Shareholder at Zafgen Inc. (ZFGN), 2015-07-24
  • Large Shareholder at Foundation Medicine Inc. (FMI), 2015-05-15
  • Director at Eleven Biotherapeutics Inc. (EBIO), 2014-03-24
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FULC $16.00 81,250 Large Shareholder, Director 5,962,202 2019-07-22 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BPMC $41.55 5,200 Large Shareholder 111,244 2017-03-16 Filing
BPMC $40.74 24,800 Large Shareholder 116,444 2017-03-16 Filing